Nevro gains on fiscal Q2 prelims

Nevro Corp. (NYSE:NVRO) shares gained today in pre-market trading after the neuromodulation company reported preliminary sales numbers for its fiscal second quarter.

Redwood City, Calif.-based Nevro said it expects to post revenues of $77.5 million to $78.0 million for the three months ended June 30, which would be a 39.9% to 40.8% increase over the $55.4 million it posted during the same period last year.

The news sent NVRO shares up 1.6% to $75.06 apiece today ahead of the market’s open on Wall Street.

Nevro predicted U.S. sales of $62.7 million to $63.0 million and overseas revenues of $14.8 million to $15.0 million. Full-year sales are pegged at $310 million to $320 million.

The company also said that sales VP Michael Enxing “is no longer with the company.”

The post Nevro gains on fiscal Q2 prelims appeared first on MassDevice.

from MassDevice http://ift.tt/2sLDOfy